Globe Life Inc. $GL Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al

Posted by Geri Gentry on May 15th, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al trimmed its position in shares of Globe Life Inc. (NYSE:GL – Free Report) by 31.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 19,800 shares of the company’s stock after selling 9,200 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Globe Life were worth $2,769,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in GL. AQR Capital Management LLC grew its holdings in Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after purchasing an additional 696,548 shares in the last quarter. Balyasny Asset Management L.P. acquired a new stake in Globe Life during the 3rd quarter valued at $80,925,000. Westfield Capital Management Co. LP acquired a new stake in Globe Life during the 3rd quarter valued at $61,569,000. Teachers Retirement System of The State of Kentucky grew its holdings in Globe Life by 2,617.6% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 182,215 shares of the company’s stock valued at $25,485,000 after purchasing an additional 175,510 shares in the last quarter. Finally, Comerica Bank grew its holdings in Globe Life by 865.4% during the 3rd quarter. Comerica Bank now owns 152,662 shares of the company’s stock valued at $21,826,000 after purchasing an additional 136,849 shares in the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have commented on GL. Wells Fargo & Company increased their price objective on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, April 10th. JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Truist Financial increased their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday. Finally, Keefe, Bruyette & Woods reiterated a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a research note on Thursday, March 26th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $172.67.

Get Our Latest Analysis on Globe Life

Insider Buying and Selling

In other news, CFO Thomas Peter Kalmbach sold 15,637 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $153.65, for a total value of $2,402,625.05. Following the transaction, the chief financial officer directly owned 45,335 shares in the company, valued at approximately $6,965,722.75. This trade represents a 25.65% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the completion of the transaction, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,192,969.04. The trade was a 25.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 107,147 shares of company stock worth $16,086,366. Company insiders own 2.11% of the company’s stock.

Globe Life Trading Up 0.9%

NYSE GL opened at $154.44 on Friday. The company’s fifty day moving average price is $145.76 and its two-hundred day moving average price is $141.04. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a 12 month low of $116.73 and a 12 month high of $156.69. The company has a market capitalization of $11.99 billion, a price-to-earnings ratio of 10.68 and a beta of 0.50.

Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the business posted $3.07 earnings per share. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, research analysts predict that Globe Life Inc. will post 15.56 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is presently 9.13%.

About Globe Life

(Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.